Track topics on Twitter Track topics that are important to you
The report presents the market potential of seven major pipeline drugs meant for the treatment of migraine. These seven drugs that fall in the various categories of Ergotamines, Anti 5HT Receptor Agonists and AntiCGRPs by mechanism of action have been recognized as being clinically effective in migraine treatment. Expected to be launched in the market within the next 45 years, these seven potential drugs are likely to bring about major changes in the way migraine is treated globally.
A comprehensive research report created through extensive primary research inputs from industry experts, companies, stakeholders and secondary research, the report aims to present the analysis of Global Migraine Pipeline Drugs Market by assessing the potential of the seven drugs that will be launched in the near future. Also, the report assesses the results of various clinical trials undertaken for each of the seven drugs, the product profile, description and regulatory phase of each of the seven drugs. Also, 7Ps Analysis Patent, Phase, Pathway, Patient, Physician, Payer, Partner has been done for each of the seven drugs to present the current perspective.
The report titled Migraine Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2022 also analyzes the overall sizing, growth and forecast of Migraine Drugs Market By Type Acute and Prophylaxis for the global market as well as for countries including United States, United Kingdom, Japan, France, Italy and Germany.
Over the recent years, the Migraine Drugs market is growing rapidly due to rising prevalence of migraine patients around the world. Globally, the growth of Migraine Drugs market is driven by rising awareness regarding migraine and available treatments
The global migraine drugs market is projected to display a robust growth represented by a CAGR of 14.48% during 2017 2022, chiefly driven by rising consumption of unhealthy food coupled with unmet need By the present drugs for the treatment of migraine. The report has covered and analysed the present migraine drugs in the market and has also analysed potential of seven major pipeline drugs. The report intends to provide cuttingedge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global migraine pipeline drugs market.
Scope of the Report
Migraine Pipeline Drugs Assessment Drug X1, X2, X3, X4, X5, X6, X7 Forecast Period: 20192022
Global Migraine Drugs Market Actual Period: 20122016, Forecast Period: 20172022
Market Sizing and Growth
Market Sizing and Growth By Type Acute and Prophylaxis
Country Analysis US, UK, Japan, France, Italy, Germany Actual Period: 20122016, Forecast Period: 20172022
Market Sizing and Growth
Other Report Highlights
Market Dynamics Drivers, Challenges
Company Analysis Amgen Biopharmaceuticals, Allergan, Eli Lilly, Alder Pharmaceuticals, Teva Pharmaceutical, Vernalis, Pfizer, Impax Laboratories, Glaxo Smithkline
Customization of the Report
The report could be customized according to the client s specific research requirements. No additional cost will be required to pay for limited additional research.NEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...